Executive Summary 5 Oman Pharmaceuticals And Healthcare Industry SWOT 6 Oman Political SWOT Industry SWOT 7 Oman Economic SWOT 7 Oman Business Environment SWOT 8 Business Environment Ranking 9 Pharmaceutical Ratings - Revised Methodology 9 Ratings Overview 9 Table: Pharmaceutical Business Environment Indicators 10 Weighting 11 Table: Weighting Of Components 11 Oman - Business Environment Ranking 12 Table: Pharmaceutical Business Environment Ratings 12 Limits Of Potential Returns 12 Risks To Realisation Of Returns 13 Market Summary 14 Regulatory Regime15 Recent Regulatory Developments 15 Intellectual Property Regime 16 Table: Current IP Laws In Oman 17 Pricing And Reimbursement 17 Regional Price Harmonisation 18 Free Trade Agreements 18 Industry Developments20 Healthcare Status 20 Table: Oman Mortality Indicators, 2004 20 Healthcare Sector 21 Table: Number Of Health Centres In Oman, By Region 21 Number and Type of Health Institutions in Oman 22 Private Healthcare Sector 23 Healthcare Reforms 24 Healthcare Reform Targets 25 Medical Tourism 25 International Collaboration 26 Pharmaceutical Sector 26 Domestic Industry 26 Foreign Industry 27 Recent Industry Developments 27 International Pharmaceutical Collaboration 28 Table: India’s Export Of Pharmaceutical Products To The GCC Countries, 2001-2005 (US$mn) 29 Industry Forecast Scenario 30 Overall Market Forecasts 30 Table: Drug Market Indicators, 2006-2012 31 Key Growth Factors - Industry 32 Table: Health Expenditure Indicators 33 Key Growth Factors - Macroeconomic 34 Table: Oman - Economic Activity 36 Prescription Market Forecast 37 Table: Prescription Market Indicators (US$mn unless otherwise stated) 38 OTC Market Forecast 39 Table: OTC Market Indicators (US$mn unless otherwise stated) 40 Generics And Patented Market Forecast 41 Table: Generics And Patented Market Indicators 42 Export/Import Market Forecasts 43 Table: Sectoral Trade Indicators, Market Share (%) 44 Other Healthcare Data Forecasts 45 Table: Other Healthcare Data Forecasts 46 Key Risk To BMI’s Forecasts 47 Competitive Landscape48 Company Monitor49 Multinationals 49 Novartis 49 Johnson & Johnson 51 Sanofi-Aventis 52 GlaxoSmithKline 53 Pfizer 54 Merck & Co 56 Bayer 57 Indigenous Manufacturers 58 Oman Pharmaceutical Products Co (OPPC) 58 National Pharmaceutical Industries (NPI) 61 BMI Forecast Modelling63 How We Generate Our Industry Forecasts 63 Pharmaceutical Industry 64 Sources 64
